Sandostatin (octreotide acetate)

**Product type:** Human Prescription Drug

**Active ingredient:** OCTREOTIDE ACETATE

**Strength:** 500 ug/mL

**Dosage form:** Injection, Solution

**Route:** Intravenous; Subcutaneous

**Labeler:** Novartis Pharmaceuticals Corporation

**Marketing category:** NDA (NDA019667)

**Pharmacologic class:** Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]